1,3-ditolylguanidine has been researched along with esketamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weigl, M; Wünsch, B | 1 |
| Amantini, C; Barocelli, E; Bertoni, S; Bonifazi, A; Cimarelli, C; Del Bello, F; Flammini, L; Mammoli, V; Nabissi, M; Pellei, M; Petrelli, R; Piergentili, A; Quaglia, W; Santoni, G; Schepmann, D; Vistoli, G; Wünsch, B | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and esketamine
| Article | Year |
|---|---|
Synthesis of bridged piperazines with sigma receptor affinity.
Topics: Cross-Linking Reagents; Molecular Structure; Piperazine; Piperazines; Receptors, sigma | 2007 |
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
Topics: Analgesics; Animals; Binding Sites; Dioxanes; Drug Design; Ligands; Mice; Models, Molecular; Pain; Phencyclidine; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor | 2015 |